This opportunity is no longer accepting applications.
grant NIH/NIAID 146

Discovery and Development of Oral Small-molecule Direct-acting Antivirals Targeting Viruses of Pandemic Potential

This grant opportunity supports focused antiviral drug discovery efforts aimed at key viral pathogens and common drug targets to build a robust pipeline of antiviral candidates. The goal is to quickly deploy drug options during viral outbreaks or pandemics. There will be 3-5 awards given. Phase I provides up to $500,000 for up to 1 year, and Phase II offers up to $2,000,000 for up to 3 years. …

Fast-Track proposals will be accepted.\nDirect-to-Phase II proposals will be accepted.\nNumber of anticipated awards: 3-5\nBudget (total costs):\nPhase I: $500,000 for up to 1 year\nPhase II: $2,000,000 for up to 3 years\nBackground\nTypical drug discovery programs require several years to progr…

Funding Source

Agency: National Institutes of Health
Program: SBIR

Dates

Opportunity Released: August 2, 2024
Open for Submission: August 2, 2024
Application Window Closes: October 18, 2024

Documents

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.